p27KIP1 is abnormally expressed in Diffuse Large B-Cell Lymphomas and is associated with an adverse clinical outcome
1999

Abnormal p27KIP1 Expression in Diffuse Large B-Cell Lymphomas

Sample size: 133 publication Evidence: moderate

Author Information

Author(s): Sáez Al, Sánchez E, Sánchez-Beato M, Cruz M A, Chacón I, Muñoz E, Camacho F I, Martínez-Montero J C, Mollejo M, Garcia J F, Piris M A

Primary Institution: Virgen de la Salud Hospital

Hypothesis

The study investigates the expression of p27KIP1 in Diffuse Large B-Cell Lymphomas and its correlation with clinical outcomes.

Conclusion

High levels of p27KIP1 expression in Diffuse Large B-Cell Lymphomas are associated with worse clinical outcomes.

Supporting Evidence

  • An abnormally high expression of p27KIP1 was found in Diffuse Large B-Cell Lymphomas.
  • High p27KIP1 expression is an adverse prognostic marker in both univariate and multivariate analysis.

Takeaway

This study found that a protein called p27KIP1 is often found in high amounts in a type of cancer called Diffuse Large B-Cell Lymphoma, and having a lot of it can mean the cancer is more serious.

Methodology

The study used immunohistochemical techniques on paraffin-embedded tissues to analyze p27KIP1 expression in patients with known clinical outcomes.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690539

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication